Loss of Grp170 results in catastrophic disruption of endoplasmic reticulum functions

GRP170, a product of the gene, is required for mouse embryonic development, and its ablation in kidney nephrons leads to renal failure. Unlike most chaperones, GRP170 is the lone member of its chaperone family in the ER lumen. However, the cellular requirement for GRP170, which both binds non-native...

Full description

Saved in:
Bibliographic Details
Published inbioRxiv : the preprint server for biology
Main Authors Mann, Melissa J, Melendez-Suchi, Chris, Sukhoplyasova, Maria, Flory, Ashley R, Carson Irvine, Mary, Iyer, Anuradha R, Vorndran, Hannah, Guerriero, Christopher J, Brodsky, Jeffrey L, Hendershot, Linda M, Buck, Teresa M
Format Journal Article
LanguageEnglish
Published United States 20.10.2023
Online AccessGet more information

Cover

Loading…
More Information
Summary:GRP170, a product of the gene, is required for mouse embryonic development, and its ablation in kidney nephrons leads to renal failure. Unlike most chaperones, GRP170 is the lone member of its chaperone family in the ER lumen. However, the cellular requirement for GRP170, which both binds non-native proteins and acts as nucleotide exchange factor for BiP, is poorly understood. Here, we report on the isolation of embryonic fibroblasts from mice in which LoxP sites were engineered in the loci ( ). A doxycycline-regulated Cre recombinase was also stably introduced into these cells. Induction of Cre resulted in excision of and depletion of Grp170 protein, culminating in apoptotic cell death. As Grp170 levels fell we observed increased steady-state binding of BiP to a client, slowed degradation of a misfolded BiP substrate, and BiP accumulation in NP40-insoluble fractions. Consistent with disrupted BiP functions, we observed reactivation of BiP storage pools and induction of the unfolded protein response (UPR) in futile attempts to provide compensatory increases in ER chaperones and folding enzymes. Together, these results provide insights into the cellular consequences of controlled Grp170 loss and insights into mutations in the locus and human disease.
DOI:10.1101/2023.10.19.563191